GloPID-R Sec III
GloPID-R Sec III
批准号:
10061268
负责人:
金额:
$99.55万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
GloPID-R-Sec III is the Secretariat to the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). Charité Universitätsmedizin Berlin (CHARITÉ) has decided to fulfil the role of Coordinator of the Secretariat, in close consultation with Fondation Mérieux (FMER; previous Secretariat coordinator) and the University of Oxford (UOXF; continuing key technical partner). As GloPID-R is continuously evolving its organization and structure, so must the Secretariat evolve. GloPID-R Sec III provides the opportunity to move towards a collaborative leadership model, aligned with GloPID-R’s vision, aiming to respond to the increased willingness from funders to work together, and to the increased work scope for GloPID-R and the Secretariat due to the lessons learned from the COVID-19 pandemic. The objectives and core activities of GloPID-R Sec III encompass: -Core organisational and secretarial services: To provide operational secretarial, organisational, and administrative support to the GloPID-R organisation; -Communication and stakeholder engagement support-oriented services: To implement, maintain and evaluate an effective external communications and advocacy programme to support communications with GloPID-R Members and stakeholders; -Technical support-oriented services: To support the further development and operationalisation of GloPID-R’s strategy by providing expert technical and operational support to its Executive Board and Working Groups. Critically, to meet the expectations of GloPID-R, the Secretariat must continuously explore and implement key adaptations that improve the effective coordination between (inter)national funders and stakeholders for a rapid research response to public health emergencies. Thus, our work plan has been devised to adjust to the anticipated evolution of the alliance and to the changes that occurred during the previous funding period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
工业大麻内生菌SEC-024A高效抑菌VOCs的合成调控、诱变选育及其增效分子机制研究
-
批准号:2026JJ81271
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王吐虹
-
依托单位:
蟾毒灵通过SEC13/HMGB1/TLR4/NF-κB轴调控转移生态位抑制乳腺癌骨转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:殷佩浩
-
依托单位:
SEC61A2调控EMT影响肺腺癌细胞侵袭和转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:徐磊
-
依托单位:
膀胱癌细胞中TEAD4激活SEC61G通过糖酵解促进M2巨噬细胞极化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李朋
-
依托单位:
金葡菌肠毒素SEC 激活内皮细胞 PDK/AKT/mTOR 信号轴介导血管新生的分子
机制研究
-
批准号:24ZR1448300
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:易磊
-
依托单位:
SEC14L3 通过 CCN1调控心肌细胞凋亡在脓毒症诱导的
心功能障碍中的作用及机制研究
-
批准号:2024JJ3038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张伟志
-
依托单位:
毕赤酵母中Sec16p蛋白介导的膜泡出芽机制解析及运输系统重塑
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕雪芹
-
依托单位:
Circ-SEC23B通过ceRNA机制调控CD24/Siglec10表达介导巨噬细胞M1极化参与Graves病免疫炎症的机制研究
-
批准号:2024Y9411
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:白雪凤
-
依托单位:
全基因组CRISPR筛选鉴定SEC23A驱动胃黏膜肠化生的作用和机制研究
-
批准号:2024Y9191
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:魏旭劲
-
依托单位:
基于胶质瘤类器官模型探讨SEC16B/TRIM56/HMGA1信号轴通过调控DNA损伤修复介导胶质母细胞瘤对替莫唑胺治疗耐药的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:黄广龙
-
依托单位: